stockrow
Friday 6 November 2026
Export TMDX’s income statement to Excel — free account
TransMedics Group, Inc.
TMDX Healthcare Medical Devices
TransMedics Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $605.5 million, up 37.1% from fiscal 2024.
- Revenue
- +41.2%
- EPS
- −31.0%
- Free cash flow
- −55.4%
- Total debt
- −89.3%
Quarter to September 2026, against a year earlier
88.15
19.17
+27.79%
Follow TMDX
Alert me
| Sep '26 From the 10-Q filed 5 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
4 | 3 | 4 | 7 |
+8 more TTM periods Free account |
| 31.89% | 36.28% | 45.22% | 54.24% | ||
| 11.73% | 12.88% | 15.13% | 20.33% | ||
ROIC |
48.00% | 5.62% | 6.64% | 13.65% | |
Return on Tangible Assets |
15.77% | 16.52% | 19.34% | 21.72% | |
Average Days of Receivables |
57.65 | 56.86 | 52.08 | 50.81 | |
Free Cash Flow per Share |
1.29 | 2.29 | 4.40 | 3.93 | |
Free Cash Flow |
44.70 | 79.04 | 151.36 | 133.59 | |
Capital Expenditures |
(67.66) | (66.89) | (68.87) | (59.25) | |
| Other line items | |||||
Cash ROIC |
4.07% | 4.27% | 8.35% | 9.06% | |
Accounts Receivable Turnover |
7.44 | 6.40 | 5.46 | 6.65 | |
Accounts Payable Turnover |
27.01 | 24.60 | 23.93 | 23.51 | |
Inventory Turnover |
5.86 | 5.94 | 5.58 | 5.09 | |
Average Days of Payables |
12.29 | 17.06 | 15.65 | 15.57 | |
Days of Inventory on Hand |
70.73 | 71.56 | 70.00 | 73.52 | |
Tax Rate |
0.96 | 1.09 | 0.92 | 0.77 | |
Research and Development Expense of Revenue |
14.62% | 13.83% | 12.07% | 11.40% | |
Selling, General and Administrative Expense of Revenue |
32.10% | 32.65% | 32.16% | 30.58% | |
Share Based Compensation of Revenue |
5.57% | 5.55% | 5.95% | 6.09% | |
Interest Coverage |
3.46 | 3.84 | 5.40 | 7.88 | |
Operating CF/Net income |
0.78 | 0.96 | 1.28 | 1.01 | |
Depreciation/Fixed assets |
0.11 | 0.10 | 0.09 | 0.08 | |
Capex/Depreciation |
(1.67) | (1.84) | (2.09) | (2.18) | |
Revenue per Share |
20.98 | 19.33 | 18.49 | 17.81 | |
Operating CF per Share |
3.24 | 4.22 | 6.40 | 5.67 | |
Capex per Share |
(1.95) | (1.93) | (2.00) | (1.74) | |
Capex to Sales |
0.09 | 0.10 | 0.11 | 0.10 |
Columns are period end dates · fundamentals updated 5 Nov 2026